Article
Recombinant modified vaccinia virus Ankara expressing a soluble form of glycoprotein B causes durable immunity and neutralizing antibodies against multiple strains of human cytomegalovirus.
Journal of virology - 1 Apr 2004
Wang Zhongde, La Rosa Corinna, Maas Rebecca, Ly Heang, Brewer John, Mekhoubad Shahram, Daftarian Pirouz, Longmate Jeff, Britt William J, Diamond Don J
Abstract excerpt
Human cytomegalovirus (CMV) is a viral pathogen that infects both genders, who remain asymptomatic unless they receive immunosuppressive drugs or acquire infections that cause reactivation of latent virus. CMV infection also causes serious birth defects following primary maternal infection during gestation. A safe and effective vaccine to limit disease in this population continues to be elusive. A well-studied...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
